Cargando…
Emerging drug development technologies targeting ubiquitination for cancer therapeutics
Development of effective cancer therapeutic strategies relies on our ability to interfere with cellular processes that are dysregulated in tumors. Given the essential role of the ubiquitin proteasome system (UPS) in regulating a myriad of cellular processes, it is not surprising that malfunction of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112620/ https://www.ncbi.nlm.nih.gov/pubmed/30851297 http://dx.doi.org/10.1016/j.pharmthera.2019.03.003 |